Do GLP-1s belong in dermatology? Evidence suggests a growing role

GLP-1 receptor agonists are best known for treating type 2 diabetes and obesity, yet a growing body of evidence suggests their benefits may extend well beyond metabolic disease to dermatologic indications. “GLP-1s are the surprise anti-inflammatory that no one saw coming,” Mona Shahriari, MD, FAAD, associate clinical professor of dermatology at Yale University School of Medicine, told